Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2025-12-24 @ 3:59 PM
NCT ID:
NCT00370292
Eligibility Criteria:
Inclusion Criteria
* Histologically or cytologically proven IIIB and IV NSCLC.
* No symptomatic uncontrolled brain metastasis
* Not suitable for platinum containing regimens if chemo-naive
* Performance status less than or equal to 2 on the Eastern Cooperative Oncology Group (ECOG) Scale.
* Creatinine Clearance (CrCl) greater than or equal to 45 milliliters per min (mL/min)
Exclusion Criteria
* Prior radiation to greater than 25% of bone marrow
* Inability to interrupt Aspirin at doses of greater than 1.3 grams/day or non-steroidal anti-inflammatory agents for a 5-day period.
* Presence of clinically relevant third-space fluid collections not controllable.
* Significant cardiac disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00370292
Study Brief:
Protocol Section:
NCT00370292